Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

This was significant because we are moving more towards the utilization of active surveillance in the United States, explains Brawer. With the statistics involving African Americans, it is important to know whether tests are reliable. With respect to Prolaris, it was necessary to determine if the test worked for all patient populations, states Brawer.